| 2022 | Association of MGMT Gene Promoter Methylation With Clinicopathological Parameters in Patients With Wild-type IDH Glioblastoma | ANTICANCER RESEARCH |
| 2019 | Clinicopathological and Molecular Characteristics of Mammary Adenoid Cystic Carcinoma With Adipocytic Differentiation With Emphasis on the Identification of a Novel BRAF Mutation | ANTICANCER RESEARCH |
| 2018 | Clinicopathological Characteristics and KRAS Mutation Status of Endometrial Mucinous Metaplasia and Carcinoma | ANTICANCER RESEARCH |
| 2022 | Clinicopathological Characteristics of Advanced Epstein-Barr Virus-associated Gastric Cancer Highlighting Aberrant p53 Expression | ANTICANCER RESEARCH |
| 2018 | Clinicopathological Characteristics of High-grade Squamous Intraepithelial Lesions Involving Condyloma Acuminatum | ANTICANCER RESEARCH |
| 2017 | Clinicopathological Characteristics of Metaplastic Papillary Tumor of the Fallopian Tube | ANTICANCER RESEARCH |
| 2017 | Clinicopathological Characteristics of Mitotically-active Cellular Fibroma of the Ovary: A Single-institutional Experience | ANTICANCER RESEARCH |
| 2018 | Clinicopathological Characteristics of Ovarian Metastasis from Colorectal and Pancreatobiliary Carcinomas Mimicking Primary Ovarian Mucinous Tumor
| ANTICANCER RESEARCH |
| 2017 | Clinicopathological Characteristics of Ovarian Sclerosing Stromal Tumor with an Emphasis on TFE3 Overexpression | ANTICANCER RESEARCH |
| 2020 | Clinicopathological Significance of MTUS1 Expression in Patients With Renal Cell Carcinoma | ANTICANCER RESEARCH |
| 2017 | CTNNB1 Mutations in Ovarian Microcystic Stromal Tumors: Identification of a Novel Deletion Mutation and the Use of Pyrosequencing to Identify Reported Point Mutation | ANTICANCER RESEARCH |
| 2018 | Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma | ANTICANCER RESEARCH |
| 2017 | Down-regulation of Inositol Polyphosphate 4-Phosphatase Type II Expression in Colorectal Carcinoma | ANTICANCER RESEARCH |
| 2016 | Down-regulation of MicroRNA-126 in Glioblastoma and its Correlation with Patient Prognosis: A Pilot Study | ANTICANCER RESEARCH |
| 2018 | Expression of Zinc Finger and BTB Domain-containing 7A in Colorectal Carcinoma | ANTICANCER RESEARCH |
| 2018 | Fluorescence-guided Surgery with Splenic Preservation Prevents Tumor Recurrence in an Orthotopic Nude-mouse Model of Human Pancreatic Cancer | ANTICANCER RESEARCH |
| 2018 | HSP27, ALDH6A1 and Prohibitin Act as a Trio-biomarker to Predict Survival in Late Metastatic Prostate Cancer | ANTICANCER RESEARCH |
| 2016 | Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast | ANTICANCER RESEARCH |
| 2019 | Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer | ANTICANCER RESEARCH |
| 2019 | Lower Sympathetic Nervous System Density and β-adrenoreceptor Expression Are Involved in Gastric Cancer Progression | ANTICANCER RESEARCH |
| 2012 | Nuclear expression of Yes-associated protein 1 correlates with poor prognosis in intestinal type gastric cancer | ANTICANCER RESEARCH |
| 2017 | Predictive Value of Sphingosine Kinase 1 Expression in Papillary Thyroid Carcinoma | ANTICANCER RESEARCH |
| 2019 | Promoter Methylation Down-regulates B-cell Translocation Gene 1 Expression in Breast Carcinoma | ANTICANCER RESEARCH |
| 2019 | Promoter methylation down-regulates osteoprotegerin expression in ovarian carcinoma | ANTICANCER RESEARCH |
| 2017 | Stromal p16 Overexpression in Adult Granulosa Cell Tumors of the Ovary | ANTICANCER RESEARCH |
| 2018 | Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine Cervix | ANTICANCER RESEARCH |
| 2017 | TP53 Mutation Status of Tubo-ovarian and Peritoneal High-grade Serous Carcinoma with a Wild-type p53 Immunostaining Pattern | ANTICANCER RESEARCH |
| 2019 | Twist and Snail/Slug Expression in Oropharyngeal Squamous Cell Carcinoma in Correlation With Lymph Node Metastasis | ANTICANCER RESEARCH |
